Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cashflow Statement

AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹5,112 Cr₹5,066 Cr₹4,380 Cr₹2,613 Cr₹3,373 Cr
Adjustment ₹2,083 Cr₹1,834 Cr₹1,496 Cr₹1,586 Cr₹1,344 Cr
Changes In working Capital ₹164 Cr₹-1,244 Cr₹-1,675 Cr₹-1,095 Cr₹1,558 Cr
Cash Flow after changes in Working Capital ₹7,358 Cr₹5,656 Cr₹4,201 Cr₹3,104 Cr₹6,275 Cr
Cash Flow from Operating Activities ₹5,526 Cr₹3,925 Cr₹2,435 Cr₹2,387 Cr₹5,016 Cr
Cash Flow from Investing Activities ₹-3,459 Cr₹-1,876 Cr₹-4,256 Cr₹-3,978 Cr₹-3,212 Cr
Cash Flow from Financing Activities ₹-1,269 Cr₹120 Cr₹800 Cr₹1,814 Cr₹-2,969 Cr
Net Cash Inflow / Outflow ₹799 Cr₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr
Opening Cash & Cash Equivalents ₹5,564 Cr₹3,385 Cr₹4,392 Cr₹4,163 Cr₹5,330 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations ₹0.18 Cr₹0.66 Cr-₹6.41 Cr₹-3.25 Cr
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹829 Cr₹9.10 Cr₹14 Cr₹-0.06 Cr₹0.20 Cr
Closing Cash & Cash Equivalent ₹7,191 Cr₹5,564 Cr₹3,385 Cr₹4,392 Cr₹4,163 Cr

Compare Cashflow Statement of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹95,303.5 Cr 1.6% 4.6% 63.6% Stock Analytics


No other companies found in this Industry


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.6%

4.6%

63.6%

SENSEX

-1.2%

-2.6%

-5.2%


You may also like the below Video Courses